Welcome Message
On behalf of the members of the Organizing Committee, we are honored to
welcome you to the 5nd Global
Conference on Tissue engineering and regenerative medicine, Stem cell Research which is going to be
slated on March 23-24, 2022 in Paris, France with theme “Novel insight and innovations
in stem cell”
Global Conference on Tissue engineering and regenerative medicine, Stem
cell 2023 will focus on many interesting scientific sessions and covers
all frontier topics in Regenerative medicine which include Tissue Engineering, Stem Cells
and Development, Organ Regeneration, 3D Bio-Printing and Organ Printing, Embryonic Stem Cells
as a Powerful Tool, Cancer and stem cells, Stem cell therapy, Stem cells and tissue banks, Regenerative Medicine
and Surgery, Hematopoietic stem cell transplantation ,Stem Cells and Their Niches.
About Conference
The 5th Global Conference on Tissue Engineering and
Regenerative Medicine, Stem Cell Research which is scheduled during March 23-24, 2023 | Paris,France is focused on theme “Exploring innovation in Tissue
Engineering and Regenerative Medicine” and to put forth the eminent research
and development in eminent field of regenerative medicine and stem cells which the plays
curial role in current and prospective technologies .The conference emphasizes
on the vital role of stem cells and regenerative medicine in field of medicine
and healthcare current trends in stem cell technology and future aspects of
building the functional and infrastructural concept of stem cell therapy.
Encompasses the spectrum of regenerative sciences from discovery to application
and focuses on providing with understanding that spans traditional academic
disciplines. It has innovative education experiences to produce the expert
scientists needed to create the next generation of regenerative diagnostic and
therapeutic solutions.
Regenerative medicine, the foremost recent and emerging
branch of bioscience, deals with functional restoration of tissues or organs
for the patient with severe injuries or chronic disease. The spectacular
progress within the field of vegetative cell research has laid the inspiration
for cell based therapies of disease which cannot be cured by conventional
medicines. The indefinite self-renewal and potential to differentiate into
other kinds of cells represent stem cells as frontiers of regenerative
medicine. The Trans differentiating potential of stem cells varies with source
and consistent with that regenerative applications also change. Advancements in
gene editing and tissue engineering technology have endorsed the ex vivo
remodeling of stem cells grown into 3D organoids and tissue structures for
personalized applications. This review outlines the foremost recent advancement
in transplantation and tissue engineering technologies of ESCs, TSPSCs, MSCs,
UCSCs, BMSCs, and iPSCs in regenerative medicine. Additionally, it also
discusses stem cells regenerative application in wildlife conservation.
This conference plays a world platform for biomedical
companies, start-ups, clinical research divisions, professionals, specialists,
consultants, doctors, scholars and students to border new relationship and
strengthen the Knowledge. This can be an excellent opportunity for all the
delegates from Universities and Institutes to interact with the highest grade
world class Scientists. The actual participants can confirm their participation
through Registrations. To explore More Regarding the Recent Research in somatic
cell its application attends Regenerative Medicine 2023.
Sessions and Tracks
Track 1- Tissue Engineering
Tissue engineering tries
to use the self-healing characteristics of biological tissues to regenerate and restore organ
function. To do so, cells from various origins, growth-inducing chemicals, and
a biomaterial-support termed a scaffold are utilized alone or in
combination to reconstruct organs. However, regenerating a functional tissue or
organ has proven difficult. With recent advancements in adult and embryonic
stem cell technologies, the fantasy of regenerating a full organ, or at least
sections of it, appears to be closer than ever.
·
Bioartificial organs
·
Biomimetics
· Long fiber generation
Related Associations and Societies: Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 2- Stem Cells and Development
Stem cells present in Human body are
unspecialized cells. They have the power to differentiate into any cell in an
organism and to regenerate. Stem cells exist both in embryos and adult cells.
They are specialized into many stages. Each stage reduces its developmental
potency, where its produces unipotent stem cell which can't differentiate into
as many different types of cells as a pluripotent cells.
- Adult stem cells
- Adult cells altered to have properties of embryonic stem cells
- Perinatal stem cells
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Track 3- Organ Regeneration
Organ re-construction can be done in vitro in
laboratories and made available on demand, or in vivo using regenerative
factors and a microenvironment that allows organs to grow
inside the body. The combination of stem cells with tissue engineering has
yielded significant advances, with the potential to usher in a paradigm change in regenerative
medicine.
·
Implantation
·
Biopsy
·
Cell isolation
· Scaffold
Related Associations and Societies: Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 4- 3D Bio-Printing and Organ Printing
Engineering, manufacturing, art, education, and medicine are just a few
of the fields where three-dimensional (3D) printing is driving substantial
changes. Biocompatible materials, cells, and supporting components
can now be 3D printed into complex 3D functioning living tissues, thanks to
recent advancements. To meet the demand for transplantable tissues and organs,
3D bio printing is being used in regenerative medicine. 3D bio printing has more complexities than
non-biological printing, such as material selection, cell kinds, growth and
differentiation variables, and technical obstacles associated to living cell sensitivities and tissue assembly.
Engineering, biomaterials science, cell biology, physics, and medicine must all
work together to solve these problems. Bio printing in 3D has already been used
to create and test new drugs.
·
3D-bioprinted tissue models
·
Inkjet based 3D Bio printing
·
Extrusion based 3D Bio printing
·
Laser assisted 3D Bio printing
· Stereolithographic based 3D Bio printing
Related Associations and Societies: Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 5- Embryonic Stem Cells as a Powerful Tool
Human embryonic stem cells (HESC) are
pluripotent stem cell lines produced from human blastocyst-stage embryos' inner
cell mass (ICM). They are defined by their culture's limitless ability for
self-renewal. Furthermore, their ability to generate virtually any cell type in
vivo and in vitro demonstrates their extensive developmental potential. HESC is
tremendously essential in basic and practical research because of these two characteristics.
They could also be an effective tool for understanding human development. By
expressing developmentally controlled genes and activating biological pathways in the same way that they do in
vivo, HESC can mimic embryogenesis. They can also be used to
investigate the impact of individual mutations on specific developmental
events, potentially allowing us to find crucial components.
·
Growth Factor–Induced Differentiation
·
Ectoderm Differentiation
·
Neuronal Differentiation
· Mesoderm Differentiation
Track 6- Cancer and stem cells
Cancer Stem Cells (CSCs) are a small
subpopulation of cells inside tumors with abilities of self-renewal,
differentiation, and tumorigenicity while
transplanted into an animal host. A variety of mobileular floor markers
including CD44, CD24, and CD133 are regularly used to pick out and enhance CSCs.
A regulatory community which includes microRNAs and Wnt/?-catenin,
Notch, and Hedgehog signaling pathways controls the CSC properties. The medical
relevance of CSCs has been bolstered with the aid of using rising evidence,
demonstrating that CSCs are resistant to traditional chemotherapy and radiation
remedy and that CSCs are very possibly to be the starting place of most cancers
metastasis. CSCs are believed to be an critical goal for novel anti-most
cancers drug discovery. Herein we summarize the present day expertise of
CSCs, with a focal point at the function of miRNA and epithelial mesenchymal
transition (EMT), and speak the medical software of concentrated on CSCs for
most cancers remedy.
·
BMI-1
·
Notch
· Sonic hedgehog and Wnt
Track 7- Stem cell therapy
Cell therapy involves the introduction of
cells directly into the body for the purpose of healing. The therapeutic
function propagates in single cell. For regenerative medicine, the ultimate
goal of cell therapy is to establish a long-term
transplant with the ability to carry out the organ's functions. A practical
example is a bone marrow transplant, where HSCs are the therapeutic
unit, which inserts the bone marrow and regenerates the whole blood stream.
·
Gene doping
·
Human genetic engineering
· Treatment of genetic diseases
Related Associations and Societies: Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 8- Stem cells and tissue banks
Stem cell banking or preservation is the
extraction, processing and storage of stem cells, which are stored and reserved
for future prospective, when required. Stem Cell has power to regenerate into
any tissue or organ in your body. It is due to this unique characteristic that
they have the potential to treat over life threatening conditions, and provide
numerous benefits to the baby, its siblings and the family.
·
Tissue banking
·
Tissue preservation
· Tissue storage
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Track 9- Biomaterials and Scaffold Design
A fundamental component of the regenerative endodontic process is the
presence of a scaffold for stem cells from the apical
papilla to adhere to, multiply and differentiate. The aim of this review is to
provide an overview of the biomaterial scaffolds that have been investigated to
support stem cells from the apical papilla in regenerative endodontic therapy and to identify potential
biomaterials for future research.
·
Instructive scaffolds
·
Endodontic therapy
· Blood-biomaterial interactions
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Track 10 - Regenerative Medicine and Surgery
As the population ages, there is an increasing need for organ and tissue
replacement to cope with the deterioration and disease of cardiovascular,
gastrointestinal, kidney, and musculoskeletal organs. Transplantation of live and dead donor organs
cannot currently meet this need. Regenerative medicine is an interdisciplinary
field that incorporates stem cell biology, immunology, materials science,
engineering, medicine, and surgery to develop solutions that can enhance or
replace the regenerative capacity of the body's own tissues. With such a wide
range of disciplines, it is important for different stakeholders to understand
where the overall picture of the process of developing and clinically using
regenerative medicine products fits. It also discusses recent surgical
applications in regenerative medicine.
·
Hand transplantation
·
Face transplantation
·
Lymphedema
· Preclinical modeling
Related Associations and Societies: Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 11 - COVID-19 and Convalescent Plasma
The use of convalescent plasma (CP) collected from the previously infected individuals to passively transfer antibodies as to guard or treat human’s dates back almost 100 years. Results from small cases series during the prior SARS and MERS coronavirus outbreaks suggested that the Convalescent Plasma is safe and should confer clinical benefits, including faster viral approval, particularly when administered early within the disease course1. The overwhelming majority of patients who get over COVID-19 illness develop circulating antibodies to varied SARS-CoV-2 proteins 2-3 weeks following infection, which are detectable by ELISA or other quantitative assays and sometimes correlate with the presence of neutralizing antibodies. Donations can occur as frequently as weekly for several months before antibody titers begin decreasing. Allowed donation frequency varies between blood centers. Listed below are some sites for referral of potential donors.
Related Associations and Societies: The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science |
Related Conferences: Cancer Workshops | Cell Science Congress | Biomarkers Symposium Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit
Track 12 - Techniques in stem cell research
Characterization of stem cell cultures has two main purposes. Monitoring
the integrity of the cell's genome and tracking the expression of proteins
associated with changes in pluripotency of epigenetic profiles. Proteome
analysis ensures that cells express the factors necessary to maintain
pluripotency. Confirmation of differentiation status by analysis of important
genetic and protein markers ensures correct cell type identification and
proliferation.
·
Stem cell characterization
·
Karyotyping
·
Fluorescence in situ hybridization (FISH)
· Comparative genomic hybridization
Related Associations and Societies: The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science |
Related Conferences: Cancer Workshops | Cell Science Congress | Biomarkers Symposium Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit
Track 13- Hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation (HSCT) is the
intravenous infusion of hematopoietic stem cells to restore blood cell
production in individuals with damaged or dysfunctional bone marrow or immune
systems. This approach has been utilized to treat a variety of malignant
and nonmalignant
disorders with increasing frequency during the last
half-century. Cells for HSCT can be taken from the patient (autologous
transplant), a sibling or unrelated donor (allogeneic transplant), or an
identical twin (allogeneic transplant) (syngeneic transplant). Bone marrow,
peripheral blood, umbilical cord blood, and foetal liver are all possible
cell sources.
·
Procurement of Stem Cells
·
Manipulation of Stem Cell Grafts
·
Preparative Regimens for HSCT
· Infusion of Stem Cells and Engraftment
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Track 14- Regenerative Pharmacology
Regenerative pharmacology will have far
higher development requirements. In fact, the challenges associated with
regenerative pharmacology, i.e., curative therapeutics, will in many cases
necessitate complex mixtures of compounds [i.e., growth factors such as fibroblast growth factor (FGF), epidermal growth
factor (EGF), platelet-derived growth factor, nerve growth
factor (NGF), vascular endothelial growth factor (VEGF),
insulin-like growth factor (IGF), bone morphogenic proteins (BMPs These
chemicals have far greater molecular weights (usually 10,000 to >100,000
mol. wt.) than those created historically by the pharmaceutical industry..
·
Cell mobilization
·
Chemokines
·
Genitourinary regeneration
· Musculoskeletal regeneration
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
·
Track 15 - Regenerative Medicine and Disease Therapeutics
· Human pluripotent stem cells (HPSCs) are useful model system for understanding the genetic basis of human cardiovascular diseases. HPSCs are often firmly genetically matched to patients with disease. Previously, only in unusual substance was it viable to review primary tissues like heart muscle and blood vessels obtained directly from living patients, and even in such circumstances, the quantity of tissue was limited. HPSCs produce a replacement approach that gives a unique opportunity to review human cells that are matched to the patients of interest. Because they will be propagated into very large numbers and differentiated into a spread of cell types that are relevant to cardiovascular diseases—including cardio myocytes, vascular endothelial and smooth muscle cells, and hepatocytes—HPSCs can in theory provide a limitless source of fabric with which to dissect the molecular support of the patient’s disease process within and beyond the circulatory system.
Related Associations and Societies: Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 16 - Translational Research in Stem Cell Assessments
Stem cell therapy has immense potential to
relieve human suffering and give solutions to medical issues that are now
unfulfilled. Stem cells must follow the same regulatory procedure as drugs to
reach the clinic. Investigator-initiated methods frequently use stem cells as
pharmaceuticals; therefore investigators must be aware of these regulatory
mechanisms from the beginning of the translational process. Furthermore,
because of the highly complicated nature of cells as pharmaceuticals, the translational pathway to development will necessitate
specific considerations.
·
Dose exploration
·
Patient-specific products
· Safety monitoring and follow-up to mitigate risk to the patients
Track 17 - Stem Cells and Their Niches
Stem cell growth and proliferation are controlled by their
specialized milieu, known as the stem cell niche, through direct cell-cell interactions
and chemical signals emitted from the niche, according
to research on embryonic and adult stem cells. The stromal cell ensemble and
the factors produced by them, such as sticky signals, soluble factors,
and matrix proteins, create the niche .While we have a good understanding of
how adult stem cells interact with their surroundings, the essential components
of the stem cell niche are still unknown. Furthermore,
tissue-specific stem cells are anticipated to be found in particular niches that
must be characterized further in each tissue. To advance in situ applications
of in vitro fertilization, progress in understanding and
building a stem cell niche will be required.
·
Intestinal stem cell niche
·
The hair follicle epidermal stem cell niche
· Hematopoietic stem cell niche
Related Associations and Societies: Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine | California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network
Related Conferences: Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings | Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium
Track 18 - Multiplexed genome regulation
Multiplexed modulation of endogenous genes is vital for sophisticated
gene therapy and cell engineering. CRISPR–Cas12a systems enable unique
multiple-genomic-loci targeting by processing numerous CRISPR RNAs (crRNAs)
from a single transcript; however, their low efficiency is preferred in vivo
applications. Through structure-guided protein engineering, we developed a
hyper-efficient Lachnospiraceae
bacterium Cas12a variant, termed hyperCas12a, with its
catalytically dead version hyperdCas12a showing significantly enhanced efficacy
for gene activation, particularly at low concentrations of crRNA. We demonstrate
that hyperdCas12a has comparable off-target
effects compared with the wild-type system and exhibits enhanced activity for
gene editing and repression. Delivery of the hyperdCas12a activator and a
single crRNA array simultaneously activating the endogenous Oct4, Sox2 and Klf4
genes in the retina of post-natal mice alters the differentiation of retinal
progenitor cells. The hyperCas12a system offers a versatile in vivo tool for a
broad range of gene-modulation and gene-therapy applications.
·
CRISPR Csy4
·
Multiplexing metabolic engineering
·
Gene editing
· CRISPRi
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Track 19 - Stem Cell Apoptosis & Signal Transduction
Apoptosis is a type of customized cell
demise which occurs in multicellular creatures. When a cell is prompted to
apoptosis, a few trademark cell morphological changes follow which incorporate
blebbing, cell shrinkage, atomic fracture, chromatin buildup, chromosomal DNA discontinuity, and
worldwide mRNA rot. Somewhat, the self-restoration and populace of undeveloped
cell is constrained by apoptosis. Apoptosis keeps foundational microorganism
number in balance between the lost because of separation or apoptosis and the
acquired because of the multiplication.
·
Fas-induced Apoptosis
·
TRAIL-induced Apoptosis
Track 20 - Regulation and ethics of stem cells
Stem cell research offers great promise for understanding basic mechanisms of human development and differentiation, as well as the hope for new treatments for diseases such as diabetes, spinal cord injury, Parkinson’s disease, and myocardial infarction. However, human stem cell (hSC) research also raises sharp ethical and political controversies. The derivation of pluripotent stem cell lines from oocytes and embryos is fraught with disputes about the onset of human personhood. The reprogramming of somatic cells to produce induced pluripotent stem cells avoids the ethical problems specific to embryonic stem cell research. In any hSC research, however, difficult dilemmas arise regarding sensitive downstream research, consent to donate materials for hSC research, early clinical trials of hSC therapies, and oversight of hSC research. These ethical and policy issues need to be discussed along with scientific challenges to ensure that stem cell research is carried out in an ethically appropriate manner. This article provides a critical analysis of these issues and how they are addressed in current policie
Related Associations and Societies: California's Stem Cell Agency | New York Stated Stem Cell Science | The New York Stem Cell Foundation | Stem Cell Network | Brazilian Association of Cellular
Therapy | Euro Stem Cell | German Stem Cell Network Australasian Society for Stem Cell
Research | Korean Society for Stem Cell Research | The Japanese Society for Regenerative
Medicine
Related Conferences: Tissue Science Summit | Cancer Workshops | Cell Science Congress | Biomarkers Symposium | Stem Cell Conference | Stem Cell Conferences | Regenerative Medicine Events | Tissue Engineering Meetings
Market Analysis
The field of regenerative medicine comprises of abundant strategies, which mainly includes the utilization of materials and de novo generated cells, also as various amalgamations therefore, to substitute the lost tissue, efficiently replacing it both anatomically and functionally, or to contribute to tissue restoration. The most objective of regenerative medicine is to propagate replacement tissue or organs for patients who have sustained an injury or have had a disease that permanently damaged their tissue. National Institutes of Health defines regenerative medicine as a process of making living, functional tissues to repair or replace tissue or organ function lost thanks to age, disease, damage, or congenital defects.
Regenerative Medicine Market Report Highlights
- The therapeutics segment dominated the market in 2020 due to the high usage of primary cell-based therapies along with advances in stem cell and progenitor cell therapies. The implementation of these therapies in dermatological, musculoskeletal, and dental application results in the highest share of this segment
- With the rise in R&D and clinical trials of regenerative medicines, key players are offering several consulting services leading to lucrative growth of the services segment
- The oncology segment is estimated to account for the largest revenue share by 2027 owing to the high prevalence of cancer indications, which drives the demand for better solutions. The presence of a strong pipeline of regenerative medicines for cancer treatment also supplements the segment growth
- North America dominated the market in 2020 and is projected to continue its dominance over the forecast period. A significant number of universities and research organizations investigating various stem cell-based approaches for regenerative apposition in the U.S. propels the region's growth
- Asia Pacific is projected to witness the fastest CAGR over the forecast period due to the emergence of key players and rapid adoption of cell-based approaches in the healthcare